Akari Therapeutics (AKTX) Depreciation & Amortization (CF) (2014 - 2024)
Akari Therapeutics (AKTX) posted quarterly Depreciation & Amortization (CF) of $1000.0 for Q4 2024, little changed year-on-year from $1000.0 in Q1 2024, and down 92.31% on a QoQ basis from $13000.0 in Q1 2024.
Akari Therapeutics (AKTX) Depreciation & Amortization (CF) (2014 - 2024) Analysis & Trends
Akari Therapeutics (AKTX) has reported Depreciation & Amortization (CF) for 9 consecutive years, with $1000.0 the latest figure, recorded in Q4 2024.
- Quarterly Depreciation & Amortization (CF) changed 0.0% year-over-year to $1000.0 in Q4 2024, while the trailing twelve-month figure through Sep 2025 was $1000.0 (down 92.86% YoY) and the FY2024 annual result came in at $14000.0, up 250.0% from the prior year.
- Depreciation & Amortization (CF) fell to $1000.0 in Q4 2024 per AKTX's latest filing, from $13000.0 in the prior quarter.
- Over the last five years, Depreciation & Amortization (CF) for AKTX reached as high as $13000.0 in Q1 2024 and fell as low as $986.0 in Q3 2020.
- A 3-year average of $2690.7 and a median of $1000.0 in 2020 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2020 — Depreciation & Amortization (CF) plunged 78.69% — and 2024, when it jumped 1200.0%.
- Year by year, Depreciation & Amortization (CF) stood at $1000.0 in 2020, then changed by 0.0% to $1000.0 in 2023, then changed by 0.0% to $1000.0 in 2024.
- According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $1000.0, $13000.0, and $1000.0 for Q4 2024, Q1 2024, and Q4 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 41.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 91,781.47 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 55.90 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 123.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Akari Therapeutics | 86.55 Mn | 86.55 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 1,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Mar 31, 2024 | 13,000.00 |
| Mar 31, 2024 | 13,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Mar 31, 2023 | 1,000.00 |
| Mar 31, 2023 | 1,000.00 |
| Dec 31, 2020 | 1,000.00 |
| Dec 31, 2020 | 1,000.00 |
| Sep 30, 2020 | 986.00 |
| Sep 30, 2020 | 986.00 |
| Jun 30, 2020 | 3,044.00 |
| Jun 30, 2020 | 3,044.00 |
| Mar 31, 2020 | 3,877.00 |
| Mar 31, 2020 | 3,877.00 |